VB-Link Ophthalmology City Challenge Successfully Concludes with 15 Projects Competing for Three Major Awards

2023Year6June 8, VB-Link Future Healthcare Specialty Innovation Solutions Ophthalmology City CompetitionSuccessfully held at BBMG Maker Factory in Beijing! The conference featured a total ofFocus on Biopharmaceuticals, Medical Devices, and DigitalHealthcare15 ophthalmology projects in fields such as [...] were presented in roadshows in succession, for the three major awards: Most Commercially Valuable Award, Most Innovative Potential Award, and Best Development Exploration AwardCompete!

As the “windows to the soul,” visual perception is closely linked to quality of life.Psychologist Treichler confirmed through experiments that 83% of the information humans acquire comes from vision.Eye HealthAs a “high-growth, high-barrier” dual-high track, it has long been hailed as the “golden track.”. With2022With the release of the “14th Five-Year Plan for Eye Health,” the ophthalmology industry has once again beenPushed to the Forefront。

Throughout the long history of medical development, innovation has driven every transformation. The booming ophthalmology sector has attracted countless companies to flock in after careful observation.Industry Leader ContinuouslyInnovative Breakthroughs,Breaking Down Technical Barriers,Countless innovative ophthalmic products have thus emerged on the market. How can innovation projects clearly define the direction and trends of future development? How can they build bridges for communication and cooperation? And how to“Link”: Accelerating Translation Under the Empowerment of the Sci-Tech Innovation Strategy?

In this context,Future Healthcare Specialty Innovation Solutions Challenge (VB-Link Competition)Emerging in response to the times, this VB-Link Ophthalmology City Competition received registrations for over 30 ophthalmic projects. Among them, more than 30% focused on innovative pharmaceutical R&D for ophthalmic diseases such as myopia, conjunctivitis, and glaucoma, while over 40% concentrated on source innovation in ophthalmic medical devices, including intraocular lens implantation,High-quality products such as ophthalmic diagnostic equipment; furthermore, over 20% of the projects integrate cutting-edge artificial intelligence applications into ophthalmic diagnosis and treatment.After multi-dimensional screening in the preliminary round, a total of 15ItemAdvancing to the Ophthalmology City Competition, the contestants include manyThere are hospitalsProfessor，Leading Enterprise Talent，AlsoFrom the University of Oxfordhigh-quality innovation cases from universities,Covers ophthalmic materials, ophthalmic drugs, and ophthalmic devicesSurgeryequipment and other cutting-edge fields, with a rich variety of types andFrontier。

This competition attracted clinical experts and scholars from Peking Union Medical College Hospital, Capital Medical University, Beijing Friendship Hospital, Beijing Haidian Hospital, and the Neuro-Ophthalmology Committee of the Chinese Association of Research Hospitals, as well as 14 distinguished judges from investment institutions including Hetang Venture Capital, Yifang Health Industry Company, Beijing Jinke Junchuang, Shuimu Venture Capital, and Yuanming Capital.The evaluation format adopts a “roadshow + judges’ Q&A” structure, with each project allotted 10 minutes for the roadshow and 5 minutes for the judges’ Q&A.

At the start of the competition,Intellectual Property Center of Central South UniversityFang Li, Director of the Xiangya Medical Department, andBeijing Medical Robotics Industry Innovation CenterDeputy General ManagerLi QiAddress at the Challenge Competition。Fang Li affirmed the significance of this ophthalmology challenge for innovation in the ophthalmology industry, patient needs, and clinical value, and mentioned the support and promotion provided by the National Engineering Research Center for Individualized Diagnosis and Treatment Technologies.Li Qiintroduced to usBeijing Medical Robot Industry Innovation CenterHow China’s First Government-Guided Collaborative Innovation Platform for Medical Robotics Technology and Industry Provides Innovation-Enabling Services

Address by Fang Li, Director of the Xiangya Medical Division, Intellectual Property Center, Central South University

Address by Li Qi, Deputy General Manager of Beijing Medical Robot Industry Innovation Center

Following this, representatives from each competing project delivered compelling project presentations.Scene 14Senior experts and those fromOphthalmologyIndustry luminaries served as judges, evaluating the project’s basic overview and teamStrength、ProjectOutlookOutlookand other aspects through on-site questioning and scoring. Afterof the juryAssessment and scoring led to the final selection ofMost Commercially Valuable Award6names, including the world’s first artificial cornea; the world’s first and only product for treating congenital nystagmus; Oxford’s world-first intelligent bionic glasses; the world’s first intraocular fluid collection device; and the ophthalmic surgical robot team from China, which is the only one featured in the Handbook of Robotic and Image-Guided Surgery authored by global authoritative experts in surgical robotics.Most Innovative Exploration Award4 cases, includingThe First Domestically Developed Drug Targeting This Pathway for TAO to Enter Clinical Trials in China, there are also focuses on digital therapeutics, AI-powered optometry diagnosis and treatment platforms, as well as R&D equipment with femtosecond laser ophthalmic surgery as the entry point; finallyMost Promising Potential Award: 5names, including focused projects on neurodegenerative diseases of the eye, visual impairment, and optic atrophy.

     Beijing Medical Robot Industry Innovation CenterChina’s first government-guided collaborative innovation platform for medical robot technology and industry, focused on the high-end medical device sector, deeply explores clinical needs and drives technological innovation. It has established capabilities to support national policy planning, undertake scientific research tasks, and deliver sustained output advantages. Operated on a corporate basis by Beijing Shuimu Dongfang Medical Robot Technology Innovation Center Co., Ltd., the Innovation Center is committed to becoming a trusted industry partner and building a world-class industrial innovation platform. With robust medical-engineering collaboration mechanisms and clear product commercialization pathways, it constructs an integrated “industry-academia-research-application” translation chain, providing CDMO (Contract Development and Manufacturing Organization) and innovation-enablement services to high-end medical device companies, research institutes, and healthcare institutions.

Future Healthcare Achievement Transformation and Collaboration Conference (VB-Link Conference) is a premier industry event in China, initiated by VCBeat and VB100. Market-demand driven, it focuses on sharing cutting-edge insights, showcasing achievements, and facilitating matchmaking and collaboration for the transformation of medical science and technology outcomes. The conference features diverse content, including the Future Healthcare Specialty Innovation Solutions Competition (VB-Link Competition), the VB-Link Award series, White Papers on Clinical Pain Points, and a series of thematic summits. The inaugural conference is scheduled to be held annually in Tianjin on June 28–29.

The Future Healthcare Specialty Innovation Solutions Challenge is a series of events under the VB-Link Conference, aiming to provide a platform for showcasing and collaborating on early-stage innovative solutions with medical specialties as the core focus. The inaugural competition featured four specialties: ophthalmology, oncology, cardiology, and neurology. City-level competitions were held sequentially in Beijing, Shanghai, Tianjin, and Hangzhou, culminating in the grand finale in Tianjin on June 28.The Oncology Challenge is scheduled for June 10. For further event details and registration, please scan the QR code in the image!